You are looking at your offer letter from an early-stage orthopedic company.
You can understand the base salary, the bonus structure, but you run into a funny line about your stock offering that reads:
“Subject to board approval, you will be granted 10,000 of equity shares/options.”
Your eyes glaze over. It sounds great on paper, but what does it actually mean?
In my years of working in the startup trenches—one that hit a funding wall, one that hit a regulatory wall, and one that was an absolute home run—I have seen hundreds of talented orthopedic professionals treat their equity like a lottery ticket. They know it could be worth something, but they don't understand the strategy behind it.
Worse yet, I see founders make an even costlier mistake. They hoard their equity like Gollum with the Ring, refusing to dilute their ownership to attract top-tier talent or secure the capital needed to scale.
My very first lesson in business was simple: Having 1% of something is infinitely better than having 100% of nothing.
Yet, science shows our brains are wired to resist this logic. Cognitive psychology points to the "endowment effect" and loss aversion—we inherently overvalue what we curre...
